Newmont is not a clean buy right now for a beginner long-term investor, but it is also not a sell. The stock looks reasonably supported by strong analyst upgrades, solid Q1 momentum, and bullish gold-sector sentiment, yet the technical setup is only neutral and insiders are selling heavily. For an impatient investor with $50,000-$100,000 to deploy, I would not chase it at the current pre-market price of 109.06; I would hold and wait for a clearer breakout above resistance or a better entry closer to support.
NEM is in a mixed-to-neutral technical position. Price is trading pre-market at 109.06, slightly above the key pivot at 110.589 but still below immediate resistance at 116.491. The MACD histogram is -0.561, which is still negative, although it is contracting, suggesting bearish momentum is easing. RSI_6 at 44.089 is neutral, not oversold enough to signal an obvious bargain. Moving averages are converging, which usually points to a consolidation phase rather than a strong trend. The short-term pattern data suggests modest near-term upside, but the monthly expectation is negative, so the current trend is not strong enough to justify an aggressive entry.

["TD Cowen raised the price target to $129 and kept a Buy rating after strong Q1 results and record free cash flow.", "BMO Capital raised its target to $145 and remains Outperform, citing a strong start to the year and longer-term production growth potential.", "Citi and UBS both raised price targets earlier, showing a positive analyst trend overall.", "News flow on gold miners remains constructive, with bullish sentiment across gold ETFs and mining stocks.", "Hedge funds are buying aggressively, with buying up 364.37% over the last quarter.", "The company posted FY 2025 sales growth of 21% to $22.7 billion, showing strong business momentum."]
["National Bank downgraded the stock to Sector Perform, citing rising costs, Ghana tax changes, Cadia mine disruption, and production pressure at Boddington and Nevada Gold Mines.", "Insiders are selling heavily, with selling amount up 506.06% over the last month.", "MACD remains negative, so the current trend has not fully turned bullish yet.", "The stock is still below key resistance, so upside confirmation is lacking.", "The recent similar-pattern stock trend suggests possible month-ahead weakness."]
Latest quarter details were not fully provided, but the available financial summary shows strong growth momentum. FY 2025 sales increased 21% to $22.7 billion, and analysts specifically referenced strong Q1 results, record free cash flow, and improved buyback capacity. That points to healthy operational execution and improving capital returns in the most recent seasonal period discussed, which was Q1 2026.
Analyst sentiment is still net positive overall, though slightly mixed recently. Several firms raised price targets after strong Q1 results, including TD Cowen to $129, BMO to $145, UBS to $140, and Citi to $150. However, National Bank downgraded the stock to Sector Perform with a $130 target due to cost and production concerns. Wall Street’s pros view NEM as a strong cash-flowing gold producer with improving guidance and buybacks, while the cons view focuses on rising operating costs, operational disruptions, and softer near-term production. Overall, the analyst trend remains constructive, but not unanimously bullish.